US OptionsDetailed Quotes
AZN241122C62000
- 1.90
- 0.000.00%
15min DelayClose Nov 19 16:00 ET
0.00High0.00Low
1.90Open1.90Pre Close0 Volume3 Open Interest62.00Strike Price0.00Turnover38.81%IV0.16%PremiumNov 22, 2024Expiry Date1.80Intrinsic Value100Multiplier2DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.8187Delta0.1278Gamma31.51Leverage Ratio-0.1144Theta0.0035Rho25.79Eff Leverage0.0140Vega
AstraZeneca Stock Discussion
Sign in to post a comment
This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
+18
15
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$AstraZeneca (AZN.US)$
astra not woke up yet in usa 😂😂😂, but in uk, share price going down 😂😂😂
astra not woke up yet in usa 😂😂😂, but in uk, share price going down 😂😂😂
2
$Bright Minds Biosciences (DRUG.US)$ volatility moving to $Monopar Therapeutics (MNPR.US)$ instead. $AstraZeneca (AZN.US)$ owns 10% of it buy!!
1
1
$Conduit Pharmaceuticals (CDT.US)$ just to let you know, astrazeneca has a big part of this stock! $AstraZeneca (AZN.US)$
1
Chinese Stocks Surge on Return from Holidays as Euphoria Extends [CSOP Global Market Morning Report]
【China】
🔸 Chinese Stocks Surge on Return from Holidays as Euphoria Extends. Chinese stocks listed onshore jumped as trading resumed following a week-long holiday, with encouraging home sales and consumption data giving fresh impetus to a rally sparked by Beijing’s stimulus blitz. The benchmark CSI 300 Index and SSEC Index climbed almost 11% in early trading before paring its advance. The measure h...
🔸 Chinese Stocks Surge on Return from Holidays as Euphoria Extends. Chinese stocks listed onshore jumped as trading resumed following a week-long holiday, with encouraging home sales and consumption data giving fresh impetus to a rally sparked by Beijing’s stimulus blitz. The benchmark CSI 300 Index and SSEC Index climbed almost 11% in early trading before paring its advance. The measure h...
![Chinese Stocks Surge on Return from Holidays as Euphoria Extends [CSOP Global Market Morning Report]](https://ussnsimg.moomoo.com/sns_client_feed/71451441/20241008/1728367312428-c514003b5c.jpeg/thumb?area=999&is_public=true)
2
$AstraZeneca (AZN.US)$
FDA Approves Osimertinib For Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer After Chemoradiation Therapy; Recommended Dose Is 80mg Daily Until Disease Progression Or Unacceptable Toxicity
FDA Approves Osimertinib For Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer After Chemoradiation Therapy; Recommended Dose Is 80mg Daily Until Disease Progression Or Unacceptable Toxicity
1
No comment yet
zetxdivx : post this in wallstreetbets?